Showing results (11-20 of 81) with videos related to
Sort By:
Pageof 9
Critical Pathways in Cardiology|August 25, 2023
Pathway for the Diagnosis and Management of Cardiac AmyloidosisEyal Herzog, David Leibowitz, Moshe E Gatt, et al.Leukemia & Lymphoma|April 11, 2003
Chronic lymphocytic leukemia presenting with extreme hyperleukocytosis and thrombosis of the common femoral veinTali Cukierman, Moshe E Gatt, Dianna Libster, et al.Hematological Oncology|September 17, 2013
Influence of ethnicity and improved outcome of acute myeloid leukaemia: two decades of follow-up of Israeli patient cohortNeta Goldschmidt, Sara B Cohen, Moshe E Gatt, et al.Scientific Reports|March 13, 2021
Suppression of multiple myeloma by mitochondrial targetingYana Aisen, Moshe E Gatt, Rachel Hertz, et al.Leukemia & Lymphoma|November 1, 2011
High incidence of skin rash in patients with hairy cell leukemia treated with cladribineChezi Ganzel, Moshe E Gatt, Alexander Maly, et al.Journal of Clinical Medicine|April 12, 2022
Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple MyelomaEyal Lebel, Boaz Nachmias, Marjorie Pick, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|December 16, 2017
Gastrointestinal perforation in light chain amyloidosis in the era of novel agent therapy - a case series and review of the literatureAdir Shaulov, Irit Avivi, Yael Cohen, et al.International Journal of Laboratory Hematology|January 17, 2021
Serum Hevylite® assay in the differential diagnosis of patients with high suspicion of AL AmyloidosisDean Yogev, Marjorie Pick, Elena Slyusarevsky, et al.Cancer Medicine|November 24, 2021
Dose-adjusted EPOCH-R is not superior to sequential R-CHOP/R-ICE as a frontline treatment for newly diagnosed primary mediastinal B-cell lymphoma: Results of a bi-center retrospective studyYael Morgenstern, Shlomzion Aumann, Neta Goldschmidt, et al.Anticancer Research|May 13, 2015
Thymidine kinase levels correlate with prognosis in aggressive lymphoma and can discriminate patients with a clinical suspicion of indolent to aggressive transformationMoshe E Gatt, Neta Goldschmidt, Ina Kalichman, et al.Pageof 9